RHENMAN & PARTNERS ASSET MANAGEMENT AB – Neurocrine Biosciences, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$9.55M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.63% | -12K shares | 294K | $106.21 | 83K |
| Q2 2022 | share | Decrease | -9.52% | -10K shares | -583K | $97.48 | 95K |
| Q1 2022 | share | Decrease | -30.51% | -46.1K shares | -2.94M | $93.75 | 105K |
| Q4 2021 | share | Increase | +59.05% | 56.1K shares | 3.67M | $84.63 | 151.1K |
| Q3 2021 | share | Decrease | -9.52% | -10K shares | -1.10M | $95.91 | 95K |
| Q2 2021 | share | Decrease | -32.26% | -50K shares | -4.85M | $97.32 | 105K |
| Q1 2021 | share | Increase | +3.33% | 5K shares | 696K | $97.25 | 155K |
| Q4 2020 | share | Increase | +100.00% | 75K shares | 7.16M | $95.85 | 150K |
| Q3 2020 | share | 0.00% | 0 shares | -1.93M | $96.16 | 75K | |
| Q2 2020 | share | Decrease | -42.31% | -55K shares | -2.10M | $122 | 75K |
| Q1 2020 | share | Increase | +8.33% | 10K shares | -1.64M | $86.55 | 130K |
| Q4 2019 | share | Decrease | -19.79% | -29.6K shares | -581K | $107.49 | 120K |
| Q3 2019 | share | Decrease | -16.89% | -30.4K shares | -1.71M | $90.11 | 149.6K |
| Q2 2019 | share | Increase | +1.64% | 2.90K shares | -405K | $84.43 | 180K |
| Q1 2019 | share | Decrease | -11.93% | -24K shares | 1.24M | $88.1 | 177.09K |
| Q4 2018 | share | Increase | +146.20% | 119.41K shares | 4.31M | $71.41 | 201.09K |
| Q3 2018 | share | Decrease | -26.00% | -28.7K shares | -801K | $122.95 | 81.67K |
| Q2 2018 | share | Increase | +0.34% | 377 shares | 1.72M | $98.24 | 110.37K |
| Q1 2018 | share | Decrease | -6.76% | -7.96K shares | -31K | $82.93 | 110K |
| Q4 2017 | share | Increase | +2.58% | 2.96K shares | 2.10M | $77.59 | 117.96K |
| Q3 2017 | share | Decrease | -4.17% | -5K shares | 1.52M | $61.28 | 115K |
| Q2 2017 | share | Increase | +41.18% | 35K shares | 1.83M | $46 | 120K |
| Q1 2017 | share | Increase | +112.50% | 45K shares | 2.13M | $43.3 | 85K |
| Q4 2016 | share | 0.00% | 0 shares | -477.6K | $38.7 | 40K | |
| Q3 2016 | share | 0.00% | 0 shares | 207.6K | $50.64 | 40K | |
| Q2 2016 | share | Decrease | -33.33% | -20K shares | -555K | $45.45 | 40K |
| Q1 2016 | share | Increase | 0.00% | 60K shares | 2.37M | $39.55 | 60K |